Laboratory News and Research

RSS

Researchers identify new type of potential anticancer drug

Researchers at Emory University School of Medicine have identified a new type of potential anticancer drug. The compound, named FOBISIN, targets 14-3-3 proteins, important for the runaway growth of cancer cells.

13 Sep 2011

HNL to implement Altosoft's Insight system at anatomic and clinical pathology labs

Altosoft, an innovator in the field of healthcare informatics and business intelligence, today announced that Health Network Laboratories, has chosen to implement Altosoft's Insight system at its anatomic and clinical pathology labs in Pennsylvania and New Jersey. With 46 locations throughout the two states, HNL, an affiliate of the Lehigh Valley Health Network, processes nearly five and a half million clinical and anatomic pathology tests each year.

12 Sep 2011

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

Tensha Therapeutics announced today that it has raised $15 million in a Series A financing to advance the development of small molecule bromodomain inhibitors for the treatment of cancer and other conditions by regulating the transcription of disease-associated genes.

12 Sep 2011

LabCorp extends previously announced cash tender offer for Orchid Cellmark shares

Laboratory Corporation of America Holdings today announced that LabCorp is extending until 5:00 p.m., New York City time, on October 7, 2011 LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc..

12 Sep 2011

Genetically modified ‘glow cat’ for HIV/AIDS research

U.S. researcher Eric Poeschla has produced three glowing genetically modified cats by using a virus to carry a gene, called green fluorescent protein (GFP), into the eggs from which the animals eventually grew. This method of genetic modification is simpler and more efficient than traditional cloning techniques, and results in fewer animals being needed in the process.

12 Sep 2011

Crocus plant to provide a tumor killing “smart bomb”

According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb’ that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.

12 Sep 2011

Scientists successfully disrupt function of MYC cancer gene

Dana-Farber Cancer Institute scientists have successfully disrupted the function of a cancer gene involved in the formation of most human tumors by tampering with the gene's "on" switch and growth signals, rather than targeting the gene itself.

12 Sep 2011

Researchers create powerful anti-diabetic prototype drugs with lesser side effects

Researchers from Dana-Farber Cancer Institute in Boston and the Scripps Research Institute in Jupiter, Fla., report they have created prototype drugs having powerful anti-diabetic effects, yet apparently free - at least in mice - of dangerous side effects plaguing some current diabetes medications.

9 Sep 2011

Autophagy also mobilizes and exports cholesterol from cells

Researchers at the University of Ottawa Heart Institute (UOHI) have discovered that an ancient pathway called autophagy also mobilizes and exports cholesterol from cells.

9 Sep 2011

Study on insect species associated with Tibetan medicinal fungus, O. sinensis

A team of researchers from the Institute of Microbiology, Chinese Academy of Sciences (Xiao-Liang Wang and Yi-Jian Yao), summarized all the available information on the insect species associated with the Tibetan medicinal fungus Ophiocordyceps sinensis through an extensive literature survey and analyzed their relationships with the fungus. The study was published in the open access journal ZooKeys.

9 Sep 2011

Duties, role of clinical laboratory microbiologists could change significantly in the future

With the increasing availability of sophisticated technologies to rapidly diagnose and treat infectious diseases, the duties and the role of clinical laboratory microbiologists, who traditionally perform these tests, could see significant changes in the next few years. That is one of the conclusions of a series of reports published in a special supplement to the September 2011 Journal of Clinical Microbiology.

9 Sep 2011

Study identifies genes never before linked to antibiotic resistance in enterococci

An analysis of the genome of a superbug has yielded crucial, novel information that could aid efforts to counteract the bacterium's resistance to an antibiotic of last resort.

9 Sep 2011

New method for making synthetic collagen

In a significant advance for cosmetic and reconstructive medicine, scientists at Rice University have unveiled a new method for making synthetic collagen. The new material, which forms from a liquid in as little as an hour, has many of the properties of natural collagen and may prove useful as a scaffold for regenerating new tissues and organs from stem cells.

9 Sep 2011

UOHI team identifies that autophagy also mobilizes and exports cholesterol from cells

Researchers at the University of Ottawa Heart Institute (UOHI) have discovered that an ancient pathway called autophagy also mobilizes and exports cholesterol from cells.

9 Sep 2011

HJF selects three promising USU doctoral students to receive 2011-12 fellowships

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has selected three promising Uniformed Services University of the Health Sciences (USU) doctoral students to receive fellowships for the 2011-12 academic year.

9 Sep 2011

University of Maryland surgeons transplant first lungs treated with experimental repair process

Surgeons at the University of Maryland Medical Center have transplanted the first lungs treated in the United States with an experimental repair process before transplantation. The procedure is part of a five-center national clinical research trial to evaluate the efficacy of repairing, before transplant, lungs that might otherwise have been passed over as unsuitable for organ donation.

8 Sep 2011

LabCorp, UnitedHealthcare extend partnership

Laboratory Corporation of America Holdings announced today that it has extended the term of its agreement with UnitedHealthcare Insurance Company, an affiliate of UnitedHealth Group Incorporated for an additional two years. The agreement, which was effective January 1, 2007, will now continue through the end of 2018.

8 Sep 2011

Transcat announces acquisition of Newark's calibration services business

Transcat, Inc., a leading distributor of professional grade handheld test and measurement instruments and accredited provider of calibration, repair and other measurement services, announced today that it has acquired the calibration services business from Newark, a subsidiary of Premier Farnell, PLC, and entered into a strategic alliance whereby Newark will market Transcat's calibration services to its broad customer base of electronic design engineers, maintenance, repair and operations engineers, and industrial buyers.

8 Sep 2011

Abnormal levels of lysophosphatidic acid can trigger congenital hydrocephalus

Scientists at The Scripps Research Institute have found what may be a major cause of congenital hydrocephalus, one of the most common neurological disorders of childhood that produces mental debilitation and sometimes death in premature and newborn children.

8 Sep 2011

Natural ruminant trans fats are not detrimental to health

Not all trans fats are created equal and it's time for nutritional labels to reflect that reality, says a University of Alberta nutrition expert.

8 Sep 2011

Laboratory News and Research

Researchers identify new type of potential anticancer drug

HNL to implement Altosoft's Insight system at anatomic and clinical pathology labs

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

LabCorp extends previously announced cash tender offer for Orchid Cellmark shares

Genetically modified ‘glow cat’ for HIV/AIDS research

Crocus plant to provide a tumor killing “smart bomb”

Scientists successfully disrupt function of MYC cancer gene

Researchers create powerful anti-diabetic prototype drugs with lesser side effects

Autophagy also mobilizes and exports cholesterol from cells

Study on insect species associated with Tibetan medicinal fungus, O. sinensis

Duties, role of clinical laboratory microbiologists could change significantly in the future

Study identifies genes never before linked to antibiotic resistance in enterococci

New method for making synthetic collagen

UOHI team identifies that autophagy also mobilizes and exports cholesterol from cells

HJF selects three promising USU doctoral students to receive 2011-12 fellowships

University of Maryland surgeons transplant first lungs treated with experimental repair process

LabCorp, UnitedHealthcare extend partnership

Transcat announces acquisition of Newark's calibration services business

Abnormal levels of lysophosphatidic acid can trigger congenital hydrocephalus

Natural ruminant trans fats are not detrimental to health

A guide to density measurement excellence eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo